Anticancer study of heterobimetallic platinum(II)-ruthenium(II) and platinum(II)-rhodium(III) complexes with bridging dithiooxamide ligand
This study indicated that these compounds may represent valuable lead structures for the development of new anticancer agents.Graphical abstract
Source: Journal of Organometallic Chemistry - Category: Chemistry Source Type: research
More News: Adenocarcinoma | Brain | Cancer | Cancer & Oncology | Cancer Therapy | Chemistry | Colorectal Cancer | Melanoma | Neuroblastoma | Neurology | Skin Cancer | Study